SGLT2 Inhibitors
Sort by:
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
- 2,918 views
- August 21, 2018
- 22
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
- 3,363 views
- August 20, 2018
- 24
ASPC 2018 Congress on CVD Prevention
Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a Seminal Transition in DM Management
FEATURING
Mikhail Kosiborod
- 975 views
- August 10, 2018
- 3
ASPC 2018 Congress on CVD Prevention
Comprehensive Approach to Lowering CVD Risk in Diabetics
FEATURING
Yehuda Handelsman
- 778 views
- August 10, 2018
- 6
ASPC 2018 Congress on CVD Prevention
SESSION 3 - Cardiometabolic Discussion
- 23 views
- August 10, 2018
Cardiometabolic Health Congress (CMHC)
CVOT Trials for Type 2 Diabetes Treatment
FEATURING
Robert Eckel
- 870 views
- May 7, 2018
- 5
Cardiometabolic Health Congress (CMHC)
Updated Type 2 Diabetes Guidelines
FEATURING
Wendy Lane
- 727 views
- May 7, 2018
Cres Miranda
The CANVAS Trial - CANagliflozin cardioVascular Assessment Study
- 1,058 views
- February 10, 2018
- 2
Cleveland Clinic | 12th Annual Obesity Summit
What To Do After Metformin: GLP-1, SGLT2 or DPP-4?
FEATURING
Kevin Pantalone
- 2,114 views
- December 3, 2017
- 5
Complex Coronary Valvular and Vascular Cases Conference
Diabetic Management to Reduce CV Events
- 226 views
- November 14, 2017
- 1
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
FEATURING
Ralph DeFronzo
- 9,424 views
- November 10, 2017
- 64
Cardiology Fiesta 2017
Changing Landscape of CV Treatment in Type 2 Diabetes
FEATURING
Robert Chilton
- 530 views
- November 10, 2017
- 2
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
FEATURING
Silvio Inzucchi
- 39,886 views
- June 16, 2017
- 195
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
FEATURING
Derek LeRoith
- 2,237 views
- June 16, 2017
- 8